Article Details

Dual therapy for lower target LDL after stroke reduces risk for events at 5 years - Healio

Retrieved on: 2022-09-30 16:26:15

Tags for this article:

Click the tags to see associated articles and topics

Dual therapy for lower target LDL after stroke reduces risk for events at 5 years - Healio. View article details on hiswai:

Excerpt

... Bristol Myers Squibb, Merck, Pfizer, Sanofi and the French government; consultant fees from Amgen, AstraZeneca, Bayer, Bristol Myers Squibb, ...

Article found on: www.healio.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up